Synaptica Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Synaptica General Information

Description

Developer and provider of neuroscience-based biotechnology designed for drug discovery. The company develops novel drugs and diagnostic tests for the treatment of neurodegenerative and other central nervous system disorders, enabling healthcare professionals to provide efficient treatment to patients.

Contact Information

Website
www.synaptica-research.com
Formerly Known As
Costnear
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 41 Cornmarket Street
  • Oxford OX1 3HA
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 41 Cornmarket Street
  • Oxford OX1 3HA
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synaptica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 10-Aug-2021 Completed Out of Business
2. Secondary Transaction - Private 01-Jan-2004 Completed Generating Revenue
1. Early Stage VC $6.58M $6.58M Completed Generating Revenue
To view Synaptica’s complete valuation and funding history, request access »

Synaptica Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Synaptica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0308435-D0 Pharmaceutical formulation of apomorphine Inactive 11-Apr-2003
GB-0221320-D0 Antibodies to biologically-active fragment of acetylcholinesterase Inactive 13-Sep-2002
GB-0030660-D0 Screening assays Inactive 15-Dec-2000
GB-0028577-D0 Diagnostic assays Inactive 23-Nov-2000
AU-2002220822-A1 For amyloid formation inhibitors Inactive 23-Nov-2000 G01N33/944
To view Synaptica’s complete patent history, request access »

Ready to get started?

Request a free trial

Synaptica FAQs

  • When was Synaptica founded?

    Synaptica was founded in 1997.

  • Where is Synaptica headquartered?

    Synaptica is headquartered in Oxford, United Kingdom.

  • What industry is Synaptica in?

    Synaptica’s primary industry is Drug Discovery.

  • Is Synaptica a private or public company?

    Synaptica is a Private company.

  • What is Synaptica’s current revenue?

    The current revenue for Synaptica is .

  • How much funding has Synaptica raised over time?

    Synaptica has raised $6.58M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »